NASDAQ:VYGR

Voyager Therapeutics Stock Insider Trading

etoro logo Buy VYGR
*Your capital is at risk
$3.60
+0.0100 (+0.279%)
At Close: Jun 03, 2026

Voyager Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 20.41. In total, the insiders bought 4.62M and sold 313.57K VYGR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
20.41
Buy 4.62M shares
Sell 313.57K shares
59% Buy Activity
Strong Positive Correlation
Sell Signal Low Confidence
Feb 24, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 20.41.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 21, 2025
Buy
Stock Option (Right to Buy)
A-Award
Carter Todd Alfred
Chief Scientific Officer
Officer 92 000
Value: $388.2K
Feb 21, 2025
Buy
Common Stock
A-Award
Carter Todd Alfred
Chief Scientific Officer
Officer 46 000
Value: $194.1K
Feb 20, 2025
Sell
Common Stock
S-Sale
Carter Todd Alfred
Chief Scientific Officer
Officer 3 305
Value: $14.1K
Feb 20, 2025
Sell
Common Stock
S-Sale
Sandrock Alfred
President And CEO
CEO / President 11 702
Value: $49.6K
Feb 20, 2025
Sell
Common Stock
S-Sale
Swartz Robin
COO & Cbo
C-Suite Officer 3 894
Value: $16.5K
Feb 20, 2025
Sell
Common Stock
S-Sale
Swartz Robin
COO & Cbo
C-Suite Officer 3 894
Value: $16.5K
Feb 20, 2025
Sell
Common Stock
S-Sale
Sandrock Alfred
President And CEO
CEO / President 11 702
Value: $49.6K
Feb 20, 2025
Sell
Common Stock
S-Sale
Carter Todd Alfred
Chief Scientific Officer
Officer 3 305
Value: $14.1K
Feb 11, 2025
Sell
Common Stock
S-Sale
Carter Todd Alfred
Chief Scientific Officer
Officer 5 413
Value: $24.1K
Feb 11, 2025
Sell
Common Stock
S-Sale
Swartz Robin
COO & Cbo
C-Suite Officer 6 950
Value: $30.9K
Feb 11, 2025
Sell
Common Stock
S-Sale
Sandrock Alfred
President & CEO
CEO / President 16 644
Value: $74.1K
Feb 11, 2025
Sell
Common Stock
S-Sale
Fahey Sandell Jacquelyn
Chief Legal Officer
Officer 4 358
Value: $19.4K
Feb 11, 2025
Sell
Common Stock
S-Sale
Fahey Sandell Jacquelyn
Chief Legal Officer
Officer 4 358
Value: $19.4K
Feb 11, 2025
Sell
Common Stock
S-Sale
Sandrock Alfred
President & CEO
CEO / President 16 644
Value: $74.1K
Feb 11, 2025
Sell
Common Stock
S-Sale
Swartz Robin
COO & Cbo
C-Suite Officer 6 950
Value: $30.9K
Feb 11, 2025
Sell
Common Stock
S-Sale
Carter Todd Alfred
Chief Scientific Officer
Officer 5 413
Value: $24.1K
Jan 14, 2025
Sell
Common Stock
S-Sale
Swartz Robin
COO & Cbo
C-Suite Officer 3 087
Value: $15.7K
Jan 14, 2025
Sell
Common Stock
S-Sale
Carter Todd Alfred
Chief Scientific Officer
Officer 1 191
Value: $6K
Jan 14, 2025
Sell
Common Stock
S-Sale
Carter Todd Alfred
Chief Scientific Officer
Officer 1 191
Value: $6K
Jan 14, 2025
Sell
Common Stock
S-Sale
Swartz Robin
COO & Cbo
C-Suite Officer 3 087
Value: $15.7K
Dec 23, 2024
Sell
Common Stock
S-Sale
Swartz Robin
COO&cbo
C-Suite Officer 6 500
Value: $36.7K
Dec 23, 2024
Sell
Common Stock
S-Sale
Swartz Robin
COO&cbo
C-Suite Officer 6 500
Value: $36.7K
Oct 02, 2024
Sell
Common Stock
S-Sale
Fahey Sandell Jacquelyn
Chief Legal Officer
Officer 5 999
Value: $34.9K
Oct 02, 2024
Sell
Common Stock
S-Sale
Fahey Sandell Jacquelyn
Chief Legal Officer
Officer 5 999
Value: $34.9K
Oct 01, 2024
Buy
Common Stock
A-Award
Jorgensen Nathan D.
Chief Financial Officer
C-Suite Officer 80 000
Value: $468.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VOYAGER THERAPEUTICS
Voyager Therapeutics
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE